Skip to content

J. Safra Sarasin Holding AG: AMRZ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of J. Safra Sarasin Holding AG on AMRZ, newest first. How the timeline and the estimate are built.

J. Safra Sarasin Holding AG held 101,363 AMRZ shares at 2026-06-30 per its 13F-HR filed 2026-07-31.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 101,363 shares
    Change vs previous 13F +337 shares

    0.08% of the 13F portfolio, value $5,480,767.

    13F-HR 0001890222-26-000004 filed by J. Safra Sarasin Holding AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 101,026 shares
    Change vs previous 13F -11,224 shares

    0.09% of the 13F portfolio, value $5,474,298.

    13F-HR 0001890222-26-000003 filed by J. Safra Sarasin Holding AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 112,250 shares
    Change vs previous 13F +26,755 shares

    0.1% of the 13F portfolio, value $6,173,945.

    13F-HR 0001890222-26-000001 filed by J. Safra Sarasin Holding AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 85,495 shares
    Change vs previous 13F +76,846 shares

    0.07% of the 13F portfolio, value $4,116,676.

    13F-HR 0001890222-25-000008 filed by J. Safra Sarasin Holding AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 8,649 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $422,656.

    13F-HR 0001890222-25-000003 filed by J. Safra Sarasin Holding AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).